Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sandra Šupraha Goreta"'
Autor:
Jerka Dumić, Ana Cvetko, Irena Abramović, Sandra Šupraha Goreta, Antonija Perović, Marina Njire Bratičević, Domagoj Kifer, Nino Sinčić, Olga Gornik, Marko Žarak
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectiveRecreational SCUBA (rSCUBA) diving has become a highly popular and widespread sport. Yet, information on molecular events underlying (patho)physiological events that follow exposure to the specific environmental conditions (hyperbaric condit
Externí odkaz:
https://doaj.org/article/26974529344441f98da4a2dc86c01488
Publikováno v:
Physiological Reports, Vol 9, Iss 2, Pp n/a-n/a (2021)
Abstract It has been shown that one recreational SCUBA (rSCUBA) diving session is sufficient to cause changes in plasma level of cardiovascular (CV) and muscular biomarkers. To explore whether repetitive rSCUBA diving triggers an adaptive response of
Externí odkaz:
https://doaj.org/article/7b8d82e36b1343f896ab429da5afa43b
Publikováno v:
Acta Pharmaceutica
Volume 72
Issue 4
Volume 72
Issue 4
Direct oral anticoagulants (DOACs) represent a new generation of drugs that have been increasingly used in the prevention and treatment of thromboembolic states. According to the mechanism of anticoagulant action, DOACs are divided into two groups: d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12cba12f634fa5676fe7d3337672d2d
https://doi.org/10.2478/acph-2022-0034
https://doi.org/10.2478/acph-2022-0034
Autor:
Sandra Margetić, Ivana Ćelap, Arijana Lovrenčić Huzjan, Marijana Bosnar Puretić, Sandra Šupraha Goreta, Anesa Čajević Glojnarić, Diana Delić Brkljačić, Pavao Mioč, Job Harenberg, Svetlana Hetjens, Christel Weiss
In certain clinical situations, it is necessary to determine whether clinically relevant plasma levels of direct oral anticoagulants (DOACs) are present. We examined whether qualitative testing of DOACs in urine samples can exclude DOAC plasma concen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::887a6e6d5ad8403c13a4b2bfe8f86969
https://doi.org/10.1055/a-1753-2748
https://doi.org/10.1055/a-1753-2748
Autor:
Marta Kmet, Nora Nikolac Gabaj, Sandra Šupraha Goreta, Milena Hanžek, Marcela Živković, Andrea Tešija Kuna, Ivan Šamija, Marijana Jovanović, Josipa Periša, Marko Žarak, Mario Štefanović, Nevenka Stančin, Sanja Tadinac, Marijana Miler, Brankica Šimac, Valentina Vidranski, Ivana Ćelap, Ines Vukasović
Publikováno v:
Biochemia Medica
Volume 31
Issue 1
Volume 31
Issue 1
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological tests have been suggested as an additional diagnostic tool in highly suspected cases with a negative molecular test and determination of seroprevalence in populati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea16ef5466704b0883257c1292a7f0ff
http://europepmc.org/articles/PMC7852303
http://europepmc.org/articles/PMC7852303
To understand better the adaptation response of the cardiovascular system (CVS) to self-contained underwater breathing apparatus (SCUBA) diving, Galectin-3 (Gal-3) and specific CVS biomarkers were measured in plasma of 16 male recreational divers bef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::798790cbb37bd8dd615bff52ec29c86e
https://www.bib.irb.hr/1059295
https://www.bib.irb.hr/1059295
Autor:
Ivana Ćelap, Sandra Margetić, Arijana Lovrenčić-Huzjan, Vanja Bašić Kes, Ivana Kobasić, Sandra Šupraha Goreta, Diana Delić Brkljačić, Nikola Pavlović
Publikováno v:
Biochemia Medica
Volume 30
Issue 1
Volume 30
Issue 1
Clinical application of rivaroxaban and apixaban does not require therapeutic monitoring. Commercial anti-activated factor X (anti-FXa) inhibition methods for all anti-FXa drugs are based on the same principle, so there are attempts to evaluate poten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cd46cc9f70d9cd8c600f48dc13faee6
https://www.bib.irb.hr/1039155
https://www.bib.irb.hr/1039155
Publikováno v:
Arhiv za higijenu rada i toksikologiju
Nanomedicine is a booming medical field that utilises nanoparticles (NPs) for the development of medicines, medical devices, and diagnostic tools. The behaviour of NPs in vivo may be quite complex due to their interactions with biological molecules.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91de6a4984f174402f9f00aa4b63f10a
https://doi.org/10.1515/aiht-2017-68-3054
https://doi.org/10.1515/aiht-2017-68-3054
Publikováno v:
Arhiv za higijenu rada i toksikologiju
Volume 68
Issue 4
Volume 68
Issue 4
Nanomedicine is a booming medical field that utilises nanoparticles (NPs) for the development of medicines, medical devices, and diagnostic tools. The behaviour of NPs in vivo may be quite complex due to their interactions with biological molecules.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1a9cc1a4b6d0306fdf11efe015e156c3
https://repozitorij.pharma.unizg.hr/islandora/object/pharma:1556
https://repozitorij.pharma.unizg.hr/islandora/object/pharma:1556
Publikováno v:
Journal of Clinical Laboratory Analysis. 25:65-70
Congenital disorder of glycosylation type Ic (CDG‐Ic) is caused by mutations in hALG6 gene encoding α‐1,3 glucosyltransferase (NP_037471.2), an enzyme that catalyzes the addition of the first glucose residue to the growing lipid‐linked oligosa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c52e1d289d7a4a400340f75883d04f21
https://doi.org/10.1002/jcla.20425
https://doi.org/10.1002/jcla.20425